Perioperative Tislelizumab Plus Chemotherapy Versus Chemotherapy Alone in MHC-II-Positive Gastric/GEJ Cancer
Clinical trial NCT07068516 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07068516
- Sponsor
- Xiangdong Cheng
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-20
- Primary completion
- 2027-06-30
- Enrollment
- 470
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.